Cargando…
Short-Term and Long-Term Effects of Levetiracetam Monotherapy On Hematological Parameters in Children with Idiopathic Epilepsy
OBJECTIVES: Levetiracetam (LEV) is a broad-spectrum anti-seizure drug (ASD) that has been widely used in recent years. It is thought to have an effect on the release of neurotransmitters that occur as a result of vesicle fusion and exocytosis by binding to synaptic vesicle glycoprotein 2A. METHODS:...
Autores principales: | Ucar, Habibe Koc, Sarigecili, Esra, Bilen, Sevcan, Sari, Sinem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Med Bull Sisli Etfal Hosp
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098390/ https://www.ncbi.nlm.nih.gov/pubmed/37064851 http://dx.doi.org/10.14744/SEMB.2022.98523 |
Ejemplares similares
-
Pediatric anti-NMDA receptor encephalitis associated with COVID-19
por: Sarigecili, Esra, et al.
Publicado: (2021) -
Short-Term and Long-Term Effects of Levetiracetam Monotherapy on Homocysteine Metabolism in Children with Epilepsy: A Prospective Study
por: Attilakos, Achilleas, et al.
Publicado: (2019) -
Acute necrotizing encephalopathy associated with RANBP2 mutation: value of MRI findings for diagnosis and intervention
por: Sarigecili, Esra, et al.
Publicado: (2022) -
Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008) -
Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review
por: Weijenberg, Amerins, et al.
Publicado: (2015)